PLATINUM Diversity

Boston Scientific

Status: Completed

Conditions: Coronary Artery Disease; Atherosclerosis

Treatments: Device: Percutaneous coronary intervention (Promus PREMIER)

Study type: Observational

Funder types: Industry

Identifiers

NCT02240810

S2326

Details and patient eligibility

About

To compile acute procedural performance and clinical outcomes data for the Promus PREMIER everolimus-eluting coronary stent system in understudied/underserved patient populations including women and minorities.

Enrollment: 1,501 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient must be at least 18 years of age

• Patient must sign informed consent form

• Patient has received at least one Promus PREMIER stent

• Patient self-identifies as one or more of the following:

  • Female
  • Black of African Heritage
  • Hispanic/Latino
  • American Indian or Alaska native

Exclusion criteria

• Not applicable

Trial design

1,501 participants in 1 patient group

PLATINUM Diversity (Overall)

Description:

PLATINUM Diversity (Overall) population. Test device is Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (CSS)

Treatment:

Device: Percutaneous coronary intervention (Promus PREMIER)